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Abstract
Background: An increasing body of evidence now implicates acetaldehyde as a major underlying factor for the
carcinogenicity of alcoholic beverages and especially for oesophageal and oral cancer. Acetaldehyde associated
with alcohol consumption is regarded as ‘carcinogenic to humans’ (IARC Group 1), with sufficient evidence
available for the oesophagus, head and neck as sites of carcinogenicity. At present, research into the mechanistic
aspects of acetaldehyde-related oral cancer has been focused on salivary acetaldehyde that is formed either from
ethanol metabolism in the epithelia or from microbial oxidation of ethanol by the oral microflora. This study was
conducted to evaluate the role of the acetaldehyde that is found as a component of alcoholic beverages as an
additional factor in the aetiology of oral cancer.
Methods: Salivary acetaldehyde levels were determined in the context of sensory analysis of different alcoholic
beverages (beer, cider, wine, sherry, vodka, calvados, grape marc spirit, tequila, cherry spirit), without swallowing, to
exclude systemic ethanol metabolism.
Results: The rinsing of the mouth for 30 seconds with an alcoholic beverage is able to increase salivary
acetaldehyde above levels previously judged to be carcinogenic in vitro, with levels up to 1000 μM in cases of
beverages with extreme acetaldehyde content. In general, the highest salivary acetaldehyde concentration was
found in all cases in the saliva 30 sec after using the beverages (average 353 μM). The average concentration then
decreased at the 2-min (156 μM), 5-min (76 μM) and 10-min (40 μM) sampling points. The salivary acetaldehyde
concentration depends primarily on the direct ingestion of acetaldehyde contained in the beverages at the 30-sec
sampling, while the influence of the metabolic formation from ethanol becomes the major factor at the 2-min
sampling point.
Conclusions: This study offers a plausible mechanism to explain the increased risk for oral cancer associated with
high acetaldehyde concentrations in certain beverages.
Background
Acetaldehyde (ethanal, CH3CHO) is a potent volatile fla-
vouring compound found in many beverages and foods
[1-3]. In alcoholic beverages, acetaldehyde may be
formed by yeast, acetic acid bacteria, and by coupled
auto-oxidation of ethanol and phenolic compounds [3].
In a recent study, a large collective of different alcoholic
beverages (n > 1500) was evaluated. Beer (9 ± 7 mg/l,
range 0-63 mg/l) contained significantly lower amounts
of acetaldehyde than wine (34 ± 34 mg/l, range 0-211
mg/l), or spirits (66 ± 101 mg/l, range 0-1159 mg/l) [4].
According to the International Agency for Research
on Cancer (IARC), acetaldehyde associated with alcohol
consumption is regarded as ‘carcinogenic to humans’
(IARC Group 1) [5]. Evidence points to the oesophagus,
head and neck as principal sites of carcinogenicity of
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metabolically or microbiologically formed acetaldehyde.
A causal link has been found between alcohol consump-
tion and the occurrence of malignant tumours of the
oral cavity, pharynx, larynx, oesophagus, as well as of
liver, colorectum, and female breast, so that ethanol in
alcoholic beverages is also considered to be ‘carcino-
genic to humans’ (IARC Group 1) [6,7].
In vitro evidence shows that the acetaldehyde DNA-
adduct a-methyl-g-hydroxy-1,N2-propano-2’-deoxygua-
nosine (Cr-PdG) can be formed in response to acetalde-
hyde concentrations as low as 100 μM [8]. Two separate
studies have proven the mutagenic potential of Cr-PdG
in either monkey kidney cells [9], or SV40-transformed
human fibroblasts [10], where the adducts result in
mutant fractions of between 5-11%. In addition, the
Cr-PdG adducts can undergo rearrangement in double-
stranded DNA, resulting in the formation of DNA-
protein cross-links and DNA interstrand cross-links.
DNA-protein cross-links are precursor lesions to sister
chromatid exchanges, which have been observed to be
elevated in human alcoholics [6]. Both DNA-protein
cross-links and DNA interstrand cross-links are
mechanistically consistent with the generation of chro-
mosomal aberrations, which have also been observed to
be elevated in human alcoholics [6]. Acetaldehyde also
interferes with DNA repair mechanisms by inhibiting
repair enzymes [11].
Apart from the in vitro evidence, the link between
acetaldehyde and oral cancer is further substantiated by
mechanistic evidence in humans deficient in aldehyde
dehydrogenase (ALDH) [6,7]. Strong evidence exists to
show that the heterozygous genotype (ALDH2*1/*2)
contributes substantially to the development of oesopha-
geal cancer related to alcohol consumption, with up to a
12 fold increase in risk seen in heavy drinkers when
compared to carriers of the homozygous ALDH2*1/*1
genotype (which encodes the active enzyme) [12,13].
ALDH deficient humans have higher levels of acetalde-
hyde in their blood but especially in their saliva after
drinking alcohol [14-16], and higher levels of acetalde-
hyde-related DNA adducts have been measured in their
lymphocytes [17].
In addition to acetaldehyde metabolism in the gastro-
intestinal tract and in the liver, the oral and colonic
bacterial flora may also contribute considerably to acet-
aldehyde accumulation [14,15,18-25]; and for humans
with active ALDH2 nearly all acetaldehyde found in the
saliva was judged to be of microbial origin [15]. For this
reason, poor dental status or lack of oral hygiene are
associated with a higher risk for cancer of the upper
gastrointestinal tract [26-28]. In addition, chronic alco-
hol abuse leads to atrophy of the parotid glands and
reduced saliva flow, which further aids local acetalde-
hyde accumulation [29].
A quantitative risk assessment using the margin of
exposure (MOE) approach has estimated the average
exposure to acetaldehyde that is a direct component of
alcoholic beverages as being 0.112 mg/kg body weight/
day. The MOE was calculated at 498, which is consid-
ered a public health concern, and the lifetime cancer
risk would be 7.6 in 10 000. Higher risk may exist for
people exposed to higher acetaldehyde contamination,
as we have found in certain alcoholic beverages, and
exposure scenarios indicate risks in the range of 1 in
1000 [30].
Theoretical calculations that assume an equal distribu-
tion between the beverage and saliva showed that the
residual acetaldehyde concentrations in the saliva after
swallowing could be, on average, 195 μM for beer, 734
μM for wine, 1387 μM for spirits, or 2417 μM for forti-
fied wine, which are above levels previously regarded as
potentially carcinogenic [4].
The present study was conducted to evaluate acetalde-
hyde found as a direct component of alcoholic beverages
as an additional cancer risk factor to acetaldehyde
formed from ethanol. Our aim was to provide experi-
mental data to substantiate the theoretical calculations
mentioned above. In addition, we focused on differences
between sub-groups of alcoholic beverages, as there are
some epidemiological findings pointing to an increased
risk of oesophageal cancer due to consumption of speci-
fic alcoholic beverages [31].
Methods
Experimental design and sampling
The experiments were conducted within the framework
of our function as governmental food and alcohol con-
trol institution, which includes a chemical-toxicological
as well as an organoleptical evaluation of products by a
trained panel of assessors. The experiments included
only products legally sold on the market of the Eur-
opean Union (EU). Furthermore, the study only included
products that had to be organoleptically tested anyway
for other reasons, e.g. to check compliance with EU and
national regulations (such as regulation (EC) 110/2008
[32]). The CVUA Karlsruhe is permanently permitted by
German federal state law to conduct sensory testing of
alcoholic beverages in its capacity as governmental con-
trol laboratory [33]. Nevertheless, we decided to conduct
the study according to the Helsinki Declaration, and
informed consent was obtained from every participant
(which is normally unnecessary for our taste panels). All
assessors met the following criteria: (i) 20 to 60 years
old; (ii) no health problems and not taking drugs; (iii)
non smokers; (iv) non-denture wearers; (v) no dental
problems (annual dentist visits, twice daily toothbrush
use). The alcoholic beverages chosen for our experi-
ments were taken from retail trade by governmental
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food inspectors. The beverages were used as such, no
acetaldehyde or any other additives were added to the
alcoholic beverages (with the exception of distilled water
to dilute some of the beverages). All beverages were
checked for compliance with European food law [32].
The alcoholic strength in the beverages was determined
according to Ref. [34], acetaldehyde in the beverages
was checked according to Refs. [35,36].
The assessors were asked to be abstinent for at least
one day prior to the experiment. All experiments were
conducted more than 1 hour after the last meal or drink
to ensure there is no contamination of saliva with inter-
fering substances. The assessors were also asked to
uphold their standard dental hygiene (twice daily tooth-
brush use), but not to use alcohol-containing
mouthwashes, and not to ingest alcohol-containing
foodstuffs during the trial period. Compliance to these
criteria including the study selection criteria was
obtained in writing by all participants.
The alcoholic beverages were rinsed by the assessors
in their mouths for 30 sec and then spit out similar to a
wine tasting (no ingestion or swallowing was allowed).
Saliva was sampled prior to rinsing, as well as 30 sec, 2
min, 5 min and 10 min after spitting-out. Sampling was
conducted using the saliva collection system salivette®
(Sarstedt, Nümbrecht, Germany). The system consists of
cotton swabs that are gently chewed by the assessors.
Afterwards, the swab is replaced in the suspended insert
of the salivette®, which is firmly closed using a stopper.
The saliva is recovered by centrifugation of the salivette®
at 1,000 g for 2 min. The clear saliva supernatant was
used for acetaldehyde analysis.
Analytical procedure
The determination of acetaldehyde in saliva samples was
conducted using either enzymatic analysis or gas chro-
matography. The enzymatic analysis was conducted with
aldehyde dehydrogenase according to the method of
Lundquist [37,38], which is available as commercial
test-kit (acetaldehyde UV-method, Cat. No. 0668613,
R-Biopharm, Darmstadt, Germany). The detection limit
of the assay is 0.25 mg/l (5.6 μmol/l). For further details
about the method see Beutler [39].
The test-kit instructions of the manufacturer were fol-
lowed without modification. 0.2 ml of saliva supernatant
were used as sample solution. The enzymatic measure-
ment was conducted immediately (within 1 hour) after
saliva sampling to exclude losses of acetaldehyde due to
evaporation or oxidation. The spectrophotometric mea-
surements were performed on a Perkin Elmer Lambda
12 dual beam spectrometer equipped with automatic
cell changer, which allows the software-controlled mea-
surement of a sample series (n = 13) without manual
intervention.
The procedure for the gas chromatographic (GC)
analysis was previously described in detail for the deter-
mination of acetaldehyde in saliva after alcohol-contain-
ing mouthwash use [40]. Both the enzymatic and the
GC procedure were validated for the use to determine
saliva after alcoholic beverage use, which leads to higher
concentrations than used in our previous validation
after mouthwash use [40]. Artefactual acetaldehyde for-
mation was excluded by analyzing blank samples (i.e.
saliva before alcohol use) with addition of 50 μl of pure
ethanol. All samples were below the detection limit of
both the enzymatic and GC method, no artefactual acet-
aldehyde was formed. The method was further validated
using authentic saliva samples after alcohol use (2 min).
Saliva samples of five samplings were pooled and homo-
genized as quality control sample. The quality control
sample (250 μM) was then analyzed for five times with
each method. The precision of the method expressed as
coefficient of variation (CV) was 9.7% (GC) and 10.3%
(enzymatic method). The recovery of the method was
determined by spiking blank saliva samples with acetal-
dehyde (n = 6). The recovery was 102.2 ± 2.9% for GC
and 103.3 ± 5.9% (enzymatic method). As most of the
samples were above 50 μM, we have not investigated
the detection limits and only investigated a range above
20 μM, which was the lowest calibrator. The results of
both methods were not significantly different and both
methods were judged suitable for the purpose of analyz-
ing saliva samples for acetaldehyde. While the GC
method is more precise, sensitive and selective, we used
the enzymatic assay for approximately half of the sam-
ples to be analyzed, because of its lower costs and faster
analysis times.
Statistics
All data were evaluated using Unscrambler X version
10.0.1 (Camo Software AS, Oslo, Norway) and Origin
V.7.5 (Originlab, Northampton, USA). Data are sum-
marized as means and standard deviations between
assessors for each data point. Statistical dependence
between alcoholic strengths and the acetaldehyde con-
tents of the beverages and the salivary acetaldehyde
were evaluated using multiple linear regression (MLR)
and Analysis of Variance (ANOVA) for all time data
points (30 sec, 2 min, 5 min, and 10 min). The regres-
sion analysis was also conducted with the area under
the curve (AUC) for the complete time period under
investigation (0-10 min). Statistical significance was
assumed at below the 0.05 probability level.
Results
Table 1 shows the alcoholic strengths and acetaldehyde
contents of the alcoholic beverages, as well as the result-
ing average salivary acetaldehyde concentrations for the
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assessors. The assessors (up to n = 10 per beverage, see
Table 1) had an average age of 27 ± 6 years and 70%
were female. The highest salivary acetaldehyde concen-
tration was found in the saliva 30 sec after using the
beverages in all cases, and the average content was 353
± 164 μM (range: 56-1074 μM). The acetaldehyde level
then decreased at the 2-min sampling (156 ± 46 μM,
range: 41-337 μM), the 5-min sampling (76 ± 19 μM,
range 26-131 μM) and at the 10-min sampling (40 ± 18
μM, range: n.d.-94 μM). The inter-individual variation
in salivary acetaldehyde content is relatively high, with
an average CV of 48% between assessors. No apparent
gender or age related differences were seen, however,
due to the relatively homogenous ages of the probands,
the statistical power does not allow to make a definite
conclusion on an effect of age. Similarly, no statistically
significant conclusion on the effect of gender can be
gathered from the data.
Figure 1 shows typical profiles for three beverages with
different alcoholic strengths and acetaldehyde contents.
The attempt to build univariate linear models between
either the values of alcoholic strengths or acetaldehyde in
the beverages and salivary acetaldehyde concentrations
was unsuccessful. This finding was consistent for any of
the calculation methods (for AUC or for the specific time
points). Thus, the acetaldehyde concentration in saliva
clearly did not depend on only one parameter. We there-
fore used multilinear regression (MLR) to evaluate the
Table 1 Alcoholic strength and acetaldehyde content of alcoholic beverages and the resulting salivary acetaldehyde
concentrations
Salivary acetaldehyde [μM]a




Number of assessorsf 0.5 min 2 min 5 min 10 min
Beerc 5 210 1 98 ± 4 113 ± 13 44 ± 6 n.d.e
Ciderc 5.5 2529 4 428 ± 159 202 ± 72 70 ± 41 26 ± 7
Winec 13 474 3 315 ± 288 225 ± 117 115 ± 62 39 ± 30
Calvadosd 15g 411 2 93 ± 59 51 ± 16 27 ± 10 n.d.e
Sherryc 15 2583 3 291 ± 117 114 ± 77 68 ± 25 n.d.e
Vodkad 16g n.d. 3 56 ± 11 59 ± 30 36 ± 27 n.d.e
Calvadosc 40 1095 2 194 ± 70 134 ± 5 91 ± 7 68 ± 37
Vodkad 40 n.d. 2 220 ± 185 125 ± 87 96 ± 81 83 ± 64
Vodkac 40 n.d. 10 116 ± 31 86 ± 61 67 ± 25 21 ± 21
Grape marc spiritd 40 11120 1 231 ± 137 41 ± 32 26 ± 12 32 ± 15
Grape marc spiritd 40 9444 2 554 ± 359 187 ± 116 46 ± 10 94 ± 100
Tequilac 40 530 1 143 ± 54 164 ± 35 131 ± 47 59 ± 18
Grape marc spiritc 41 15197 4 1074 ± 399 256 ± 117 90 ± 60 58 ± 39
Grape marc spiritd 41 15851 3 625 ± 231 243 ± 211 103 ± 71 86 ± 69
Cherry spiritc 43 8522 1 856 ± 17 337 ± 42 123 ± 25 41 ± 9
a Salivary acetaldehyde before use was not detectable (< 20 μM) in all cases. Average and standard deviation of all assessors are shown (in the case of n = 1, the
average and standard deviation of the two replications per assessor are shown).
b Acetaldehyde directly contained in the alcoholic beverage as determined with GC analysis.
c Enzymatic analysis of salivary acetaldehyde.
d GC analysis of salivary acetaldehyde.
e Not detectable (< 20 μM).
f Two replications were conducted with each assessor on different days.
g Dilution of a commercial product at 40% vol with distilled water.
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Figure 1 Salivary acetaldehyde concentrations after alcoholic
beverage use in three different samples. The values are average
and standard deviation of all assessors. The figure legend states the
alcoholic strength (in % vol) and the acetaldehyde content (in μM) in the
beverages, as well as the number of assessors used for each beverage.
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combined influence of ethanol and acetaldehyde in the
beverages.
The results of ANOVA for the MLR calculations are
summarized in Table 2. ANOVA suggests that both glo-
bal models (for the independent time points and AUC)
are significant. Table 2 also provides ANOVA results for
the significance of individual effects on salivary acetalde-
hyde concentrations for each time point. At the first
time-point (30 sec), acetaldehyde that directly comes
from the beverages dominates in the saliva. Only a
minor influence of the ethanol content was evident dur-
ing the first 30-sec after beverage use, but it then gradu-
ally increased with an almost 100% influence from the 5
min time point (Figure 2).
Discussion
Our results confirm the observation of high inter-indivi-
dual variations in the acetaldehyde levels in saliva fol-
lowing ethanol exposure previously noted during in
vitro and in vivo experiments. These high variations
were judged to be predominantly caused by the differ-
ences in acetaldehyde production capacity among the
oral bacteria [19,40,41]. While our assessor collective
was too small for statistical investigation of sub-collec-
tives, we can nevertheless qualitatively confirm the in
vitro results of Ernstgård [41], as we saw no apparent
gender or age related differences. The small sample size
of assessors (for some of the beverages only n = 1) is
also a major limitation of the study. A further limitation
of the study includes the use of the salivette® saliva col-
lection method, which may stimulate salivary secretion
and thus dilute acetaldehyde and ethanol concentrations.
Our study therefore could underestimate rather than
overestimate the risk.
In our previous experiments on acetaldehyde in sal-
iva after use of alcohol-containing mouthwashes [40],
we did not detect any dependence between salivary
acetaldehyde and ethanol or acetaldehyde concentra-
tion of the mouthwashes. However, the concentrations
of both compounds were lower in the mouthwashes
than in the alcoholic beverages under investigation in
the present study and the previous study design had
only low statistical power. This explains that this time
within our resources to analyze around 500 samples,
our aim was to rather sample a larger number of
beverages with fewer assessors than vice versa, leading
to increased variance of ethanol and acetaldehyde con-
tents in the beverage collective and similarly increased
power for the statistical calculations on these
parameters. Nevertheless, we were still surprised that a
statistically significant dependence occurs in this case
of alcoholic beverages. In the mouthwashes (which
contained very little acetaldehyde), the metabolically
produced acetaldehyde was the predominant factor for
salivary acetaldehyde [40]. In contrast, in the case of
alcoholic beverages, salivary acetaldehyde is character-
ized by both the acetaldehyde contained in the bever-
age and that formed from ethanol.
The influence of the directly contained acetaldehyde,
however, is short-term and only prevails during the first
2 minutes after rinsing of the mouth with an alcoholic
beverage for 30 seconds. Subsequently, the concentra-
tion depends on the amount of ethanol available for
metabolic oxidation. Further research should be con-
ducted to clarify the influences in the time period
between 30 sec and 5 min in more detail, as our
approach does not allow to interpolate the exact time at
which the change between the two factors occurs.
Similar findings to our study were generally made by
Yokoyama et al. [16], with a slightly different experi-
mental design that used ingestion of different alcoholic
beverages up to the same blood alcohol concentration.
In this study, similar to our findings, the type of alco-
holic beverages had no effect on the saliva acetaldehyde
concentration 30 minutes or more after drinking, while
a beverage dependency was observed directly after the
completion of drinking (the period between 0 and 30
Table 2 ANOVA results for multiple linear regression
(MLR) models
Model for individual time pointsa Model for AUC
0.5 min 2 min 5 min 10 min
R 0.80 0.81
p (Model) 0.0022 0.0030
p (Ethanol) 0.9400 0.9200 0.1200 0.0098 0.3400
p (Acetaldehyde) 0.0002 0.0190 0.9900 0.3500 0.0057
a time after beverage use.



















Time after beverage use [min]
 Ethanol
 Acetaldehyde
Figure 2 Influence of ethanol and acetaldehyde content of the
beverages on the salivary acetaldehyde concentration.
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min was not further investigated by the authors,
however). Apart from the ingestion used, our results are
not directly comparable to those of Yokoyama et al. [16]
as they used spirits that had all been diluted to 13% vol.
Our collective of alcoholic beverages also generally con-
tained higher levels of acetaldehyde, as we intentionally
selected beverages with high contamination status for
the experiment, in order to increase the likelihood of
observing a significant effect when compared to non-
contaminated vodka. The limitation of the comparably
low sample size in our study must also be kept in mind.
Our results are therefore not generalizable for a popula-
tion-based risk assessment, as the beverages are not
representative of those available in the market. The con-
tamination status of the beverages also explains the
extremely high salivary acetaldehyde concentrations up
to over 1000 μM, which were never before described in
the literature, not even for ALDH2-deficient subjects
[14,16,19,42,43]. Our in vivo results confirm our pre-
vious theoretical calculations of potentially high short-
term acetaldehyde concentrations, as mentioned in the
introduction, which were deduced from typical levels
found in beverages [4].
This now leaves the question regarding how to inter-
pret the health effects of this short-term high exposure
to acetaldehyde. Whether a threshold for the carcino-
genicity of acetaldehyde exists is still debatable and its
potential magnitude is unclear [40]. The natural acetal-
dehyde background levels in human blood are very low
and generally not detectable (< 0.5 μM) [44] and the
endogenous salivary acetaldehyde levels are assumed to
be likewise, as they are below 1 μM [40]. This assump-
tion was recently confirmed in vitro, as an average of
0.3 μM acetaldehyde occurred in 36 saliva samples
without ethanol exposure [41]. The lowest concentra-
tion of acetaldehyde that has induced sister chromatid
exchange in Chinese hamster ovary cells in vitro (3.9
mg/l, 88 μM) in a study of Obe and Ristow was sug-
gested as threshold for toxicity evaluation [45]. This is
in agreement not only with the 100 μM threshold for
Cr-PdG formation [8], but also with indirect evidence
on salivary acetaldehyde concentration provided by
human studies on alcohol consumption. After a mod-
erate dose of alcohol, acetaldehyde levels in the saliva
range between 18 and 143 μM within 40 minutes of
alcohol ingestion [19]. After ingestion of a moderate
dose of alcohol, ALDH2-deficient Asians have detect-
able acetaldehyde levels in their saliva that are 2-3
times higher than in Asians with the normal enzyme.
This is associated with a remarkably increased risk for
digestive tract cancers [14]. Salaspuro recently sum-
marized all of this evidence and estimated that the
mutagenic amount of acetaldehyde in saliva falls
between 50 and 150 μM [46]. Linderborg et al. [31]
indicated that the oral and upper digestive tract
mucosa is exposed to a much higher acetaldehyde con-
centration after ingestion of calvados (i.e., 20-50 times
higher than those considered to be mutagenic), which
is consistent with our results.
Conclusions
Because alcohol use significantly increases salivary
acetaldehyde above endogenous levels (even if the alco-
hol is not contaminated, as in the case of vodka), we
ascertain that a “biological threshold” is clearly
exceeded during alcohol consumption. The observa-
tions of the present study and the suggested molecular
mechanisms could conceivably explain the increased
oral cancer risk associated with alcohol use seen in
epidemiological studies [6]. Salivary acetaldehyde con-
centrations in the range associated with sister chroma-
tid exchange and Cr-PdG formation are clearly
achievable. Highly contaminated beverages could pre-
sent a higher cancer risk than beverages with none or
very low concentrations of acetaldehyde (for example,
see Linderborg et al. [31]). Currently only limited and
inconclusive epidemiological evidence exists to confirm
this beverage specificity, however. From the 56 studies
on oesophageal cancer summarized by IARC [6], the
influence of the type of alcoholic beverage consumed
was examined in several studies. Consumption of beer
or hard liquor led to a higher relative risk than con-
sumption of wine [47-52], whereas two studies [53,54]
also found an excess risk for wine drinkers. Most of
the studies that investigated types of alcoholic beverage
showed no substantial difference in risk [6]. This prob-
ably derives from the fact that the most commonly
consumed beverage groups on a population scale (i.e.,
beer, wine and white spirits) are typically low in acetal-
dehyde content. It would be also challenging to design
an epidemiological study that could consider the acet-
aldehyde content, when even the ethanol amount is
often difficult to measure in retrospect [55] and inter-
national data on acetaldehyde content of alcoholic
beverages are very limited [4].
Currently, the acetaldehyde content of most alcoholic
beverage types is not regulated. The recent IARC eva-
luation of acetaldehyde associated with alcohol con-
sumption as a “group 1” carcinogen has not yet been
implemented in international risk assessments (e.g., by
JECFA or EFSA). Until such assessments become avail-
able, we would currently recommend the implementa-
tion of the ALARA principle ("as low as reasonably
achievable”) [56]. In the case of spirits, which were
linked to very high short-term acetaldehyde concentra-
tions in our study, avoidance of acetaldehyde contami-
nation is relatively easy if the first distillation fractions
are discarded [4].
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